Control Bionics Limited (ASX:CBL)
Australia flag Australia · Delayed Price · Currency is AUD
0.0550
-0.0030 (-5.17%)
Mar 18, 2026, 3:58 PM AEST

Control Bionics Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
2391082058
Market Cap Growth
50.04%-14.71%31.65%-59.75%-66.31%-
Enterprise Value
208951257
Last Close Price
0.060.030.050.080.200.62
PS Ratio
3.731.441.941.404.3414.20
PB Ratio
2.931.601.651.101.643.38
P/TBV Ratio
7.215.414.672.592.494.44
EV/Sales Ratio
3.271.351.710.892.5613.92
Debt / Equity Ratio
0.030.080.150.020.020.00
Net Debt / Equity Ratio
-0.36-0.04-0.01-0.12-0.42-0.72
Net Debt / EBITDA Ratio
0.540.050.020.180.874.12
Net Debt / FCF Ratio
0.630.050.020.170.713.05
Asset Turnover
0.650.710.600.510.280.33
Inventory Turnover
4.714.992.412.243.346.37
Quick Ratio
1.981.001.321.754.9611.47
Current Ratio
2.221.241.572.496.3311.69
Return on Equity (ROE)
-91.56%-103.74%-88.16%-59.05%-41.95%-31.03%
Return on Assets (ROA)
-40.30%-43.14%-40.69%-29.53%-24.29%-15.93%
Return on Capital Employed (ROCE)
-77.90%-104.90%-87.30%-73.10%-51.10%-18.30%
Earnings Yield
-28.67%-69.12%-57.07%-71.54%-31.20%-6.12%
FCF Yield
-19.70%-51.73%-51.24%-62.96%-35.97%-6.96%
Buyback Yield / Dilution
-41.23%-65.68%-76.64%-5.80%-36.04%-535.65%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.